Application of novel plasma separation filter cards for quantification of nucleoside/nucleotide reverse transcriptase inhibitor di/triphosphates in dried blood spots using LC-MS

Bioanalysis. 2023 Jul;15(13):739-756. doi: 10.4155/bio-2023-0057. Epub 2023 Jun 9.

Abstract

Background: A rapid and sensitive LC-MS method has been developed and validated for the quantification of nucleoside di/triphosphates using a novel plasma separation card (HemaSep). Materials & methods: Cards were spotted with whole blood and stored at -80°C. Metabolites were extracted using 70:30 MeOH:20% formic acid, followed by weak anion exchange SPE and eluted using a Biobasic-AX column. Quantification was performed using a triple quadrupole mass spectrometer with a calibration range of 1.25-250 pmol/sample. Results: The recovery of metabolites was high (>93%). Precision and accuracy were acceptable and metabolites remained stable on the card after 29 days (stored at ambient temperature). Conclusion: HemaSep dried blood spots are a useful microsampling tool and offer an alternative to liquid plasma as they maintain stability over time.

Keywords: LC–MS; adherence; antiretrovirals; dried blood spots; emtricitabine triphosphate; lamivudine triphosphate; tenofovir diphosphate.

MeSH terms

  • Chromatography, Liquid / methods
  • Dried Blood Spot Testing / methods
  • Nucleosides*
  • Nucleotides
  • Reproducibility of Results
  • Reverse Transcriptase Inhibitors*
  • Tandem Mass Spectrometry / methods

Substances

  • Reverse Transcriptase Inhibitors
  • Nucleosides
  • Nucleotides
  • triphosphoric acid